Cyclacel Pharmaceuticals Inc (CYCC)
0.41
-0.04
(-9.89%)
USD |
NASDAQ |
Nov 14, 10:36
Cyclacel Pharmaceuticals Max Drawdown (5Y): 99.76% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.76% |
| September 30, 2024 | 99.64% |
| August 31, 2024 | 99.62% |
| July 31, 2024 | 99.50% |
| June 30, 2024 | 99.50% |
| May 31, 2024 | 99.50% |
| April 30, 2024 | 99.50% |
| March 31, 2024 | 99.30% |
| February 29, 2024 | 99.28% |
| January 31, 2024 | 99.28% |
| December 31, 2023 | 99.11% |
| November 30, 2023 | 99.06% |
| October 31, 2023 | 99.06% |
| September 30, 2023 | 99.06% |
| August 31, 2023 | 99.06% |
| July 31, 2023 | 99.06% |
| June 30, 2023 | 99.06% |
| May 31, 2023 | 99.06% |
| April 30, 2023 | 99.06% |
| March 31, 2023 | 99.06% |
| February 28, 2023 | 99.06% |
| January 31, 2023 | 99.06% |
| December 31, 2022 | 99.06% |
| November 30, 2022 | 99.06% |
| October 31, 2022 | 99.06% |
| Date | Value |
|---|---|
| September 30, 2022 | 99.06% |
| August 31, 2022 | 99.06% |
| July 31, 2022 | 99.06% |
| June 30, 2022 | 99.06% |
| May 31, 2022 | 99.06% |
| April 30, 2022 | 99.06% |
| March 31, 2022 | 99.06% |
| February 28, 2022 | 99.06% |
| January 31, 2022 | 99.06% |
| December 31, 2021 | 99.06% |
| November 30, 2021 | 99.06% |
| October 31, 2021 | 99.06% |
| September 30, 2021 | 99.06% |
| August 31, 2021 | 99.06% |
| July 31, 2021 | 99.06% |
| June 30, 2021 | 99.06% |
| May 31, 2021 | 99.06% |
| April 30, 2021 | 99.06% |
| March 31, 2021 | 99.06% |
| February 28, 2021 | 99.06% |
| January 31, 2021 | 99.06% |
| December 31, 2020 | 99.06% |
| November 30, 2020 | 99.06% |
| October 31, 2020 | 99.06% |
| September 30, 2020 | 99.06% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.06%
Minimum
Nov 2019
99.76%
Maximum
Oct 2024
99.13%
Average
99.06%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 99.67% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -73.59 |
| Beta (5Y) | 0.5567 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 98.02% |
| Historical Sharpe Ratio (5Y) | -0.6775 |
| Historical Sortino (5Y) | -1.416 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.57% |